U3O8 Corp. , wishes to correct the press release issued on February 12, 2021. The Company announces that it is increasing the size of the non-brokered private placement of units of the Company originally announced on January 27, 2021 from $500,000, to gross proceeds of up to $1,000,000 . Pricing The Company intends to sell up to 6,666,666 Units at [...]
U3O8 Corp. , announces that it is increasing the size of the non-brokered private placement of units of the Company announced on January 27, 2021 from $500,000, to gross proceeds of up to $1,000,000 . Pricing The Company intends to sell up to 6,666,666 Units at a price of C$0.15 per Unit. Each Unit shall consist of a common share of the Company and [...]
U3O8 Corp. announces that its board of directors has approved undertaking a non-brokered private placement to raise gross proceeds of C$500,000 . Pricing The Company intends to sell 3,333,333 units at a price of C$0.15. Each Unit consists of a common share of the Company and a common share purchase warrant . Each Warrant entitles the holder to [...]
U3O8 Corp. announces that it has entered into an agreement whereby International Consolidated Uranium Inc. has the option to acquire the Laguna Salada uranium-vanadium deposit in Argentina. U3O8 Corp.'s President & CEO, Dr. Richard Spencer commented, "The Board of U3O8 Corp. has mapped out an alternative course for the Company that involves a [...]
U3O8 Corp. , announces that it has issued an aggregate total of 860,000 stock options to board members, management and consultants. The stock options have a five-year term and an exercise price of $0.12, corresponding to the closing price of the Company's stock on the NEX platform of the TSX Venture Exchange on August 21, 2020. These options comply [...]
U3O8 Corp. , is pleased to announce that its shareholders have approved all of the resolutions put before them at the Company's Annual General Meeting held in Toronto on Friday, August 7, 2020. Shareholders approved the financial statements for the year-ended December 31, 2019 and the report of the auditors thereon, the appointment of auditors [...]
U3O8 Corp. , reports that, further to the press release dated March 30, 2020, announcing that the Company would not be proceeding with the reverse takeover described in its March 2, 2020 press release, the Company’s submission to TSX Venture Exchange for the lifting of the halt on trading of the Company’s shares, has been accepted. Subject to final [...]
U3O8 Corp. announces that, further to the press release dated March 2, 2020, the letter of intent between the Company and Diagnostic Lab Corporation, Inc. to negotiate and complete a proposed reactivation transaction, has been terminated in accordance with the provisions of the LOI, and the transaction contemplated therein will not proceed. The [...]
U3O8 Corp. , announces that it has entered into a binding Letter of Intent dated March 2, 2020 with Diagnostic Lab Corporation, Inc. whereby the business and assets of U3O8 Corp. and DLC will be combined by way of a share exchange between U3O8 Corp. and shareholders of DLC, constituting a “reverse-takeover” of U3O8 Corp. by DLC under [...]
U3O8 Corp. , announces that, further to its press release date February 24, 2020, the Company’s listing will transfer to the NEX board of the TSX Venture Exchange effective February 27, 2020 and not February 26, 2020. The trading symbol for the Company will change from UWE to UWE.H. There is no change in the Company's name, no change in its [...]
U3O8 Corp. , announces that effective February 26, 2020 the Company's listing will transfer to the NEX board of the TSX Venture Exchange. The trading symbol for the Company will change from UWE to UWE.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX [...]
U3O8 Corp. reports that all matters brought before its shareholders were approved at the Annual General Meeting held yesterday in Toronto, Ontario. A total of 6,644,075 of the Corporation's common shares were voted by proxy and in person, representing 28.83% of the 23,043,436 shares outstanding on May 13, 2019, the record date of the AGM. Directors [...]